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Summary 
Natural killer (NK) cells express killer inhibitory receptors that mediate negative regulation of 
NK cell cytotoxicity upon binding to MHC class I molecules on target cells. Unrelated inhibi- 
tory receptors on B  cells have recently been shown to function through recruitment of phos- 
photyrosine phosphatase 1C (PTP-1C). Here, we show that a human killer inhibitory receptor 
specific for HLA-C also recruits PTP-1C after phosphorylation induced either by the pharma- 
cological agent phenylarsine  oxide or by conjugation with  target  cells.  This  recruitment is 
mediated  by  the  binding  of specific  cytoplasmic  phosphotyrosine-containing sequences  to 
PTP-1C. These results implicate PTP-1C as a cytosolic component of the negative signaling 
pathway through NK cell inhibitory receptors. 
C 
Ytotoxicity by NK cells is controlled by an interplay 
of signals  from both  stimulatory and  inhibitory cell 
surface receptors (1). Activating receptors trigger NK cell- 
mediated cytotoxicity upon binding to specific target cell 
ligands.  Killer  inhibitory  receptors  (KIRs) 1 engage  with 
MHC class I molecules on target cells, blocking the func- 
tional  capacity of the  stimulatory receptors. When  target 
cells lose or reduce expression of MHC class I molecules as 
a consequence of transformation or viral infections, the bal- 
ance between activation and inhibition is altered, resulting 
in the release of target-directed NK cell cytotoxicity. 
Human KIRs have recently been identified by mAbs and 
cDNA  cloning as  transmembrane  glycoproteins of the  Ig 
superfamily that recognize the distinct polymorphic deter- 
minants of  HLA-B and -C molecules (2-7). Structurally, the 
extracellular region of these receptors is composed of two 
(HLA-C receptors) or three  (HLA-B receptors) Ig super- 
family domains.  The cytoplasmic region includes  a motif 
characterized by  two  tyrosine-x-x-leucine  (YXXL)  pairs 
spaced by 26 amino acids. A subgroup of KIRs lack this mo- 
tif  because of a premature truncation of the cytoplasmic tail 
and function as activatory rather than inhibitory receptors (8). 
Recent observations in B cells have suggested a potential 
role  for  these  cytoplasmic  tyrosines  in  the  function  of 
KIRs.  The B  cell-surface receptors Fc~/RIIB1  and CD22 
are  characterized  by  cytoplasmic  tyrosine-containing  se- 
quences,  termed  immune  receptor tyrosine-based inhibi- 
tory motifs (ITIM) (9-12), which bind the SH2 domain(s) 
of protein tyrosine phosphatase-lC  (PTP-1C, also known 
as SHPTP-1, SHP, or HCP; 13-16) upon phosphorylation 
(9, 17). Coligation of FcgRIIB1 with the B cell antigen re- 
ceptor (BCR)  induces ITIM tyrosine phosphorylation, re- 
cruitment of PTP-1C, and subsequently inhibits the capac- 
ity of the BCR to activate phospholipase C and to mobilize 
calcium  (9).  Similarly,  CD22,  which  is  weakly associated 
with BCR,  becomes tyrosine phosphorylated and recruits 
PTP-1C  upon BCR  cross-linking (17).  Separating CD22 
from BCR with anti-CD22 antibody can substantially en- 
hance proliferative responses induced by BCR cross-link- 
ing (17). The ITIM motit~ in CD22 and Fc~/RIIB1 are sur- 
prisingly similar to the YXXL motifs of the human KIRs. 
A further parallel with CD22 and Fc',/RIIB1 is the observa- 
tion that ligation of inhibitory receptors by MHC  class I 
molecules on target cells inhibits the calcium mobilization 
in NK cells induced by susceptible target cells (18). 
These structural and functional parallels between the hu- 
man KIRs and the CD22 and Fc',/RIIB1 receptors have sug- 
gested a role for a phosphatase in KIR function (5, 19). There- 
fore, we investigated whether the KIRs also bind PTP-1C 
upon tyrosine phosphorylation. The results  indicate that a 
human p58 KIR specific for HLA-C indeed binds PTP-1C 
upon phosphorylation of either tyrosine residue. 
1Abbreviations used in this paper: BCR, B cell antigen receptor; FSC, for- 
ward scatter; HRP, horseradish peroxidase; ITIM, immune receptor ty- 
rosine-based inhibitory motifs; KIR, killer inhibitory receptors; PAO, 
phenylarsine oxide;  PTP-1C, phosphotyrosine  phosphatase 1C. 
Materials and Methods 
Cell Lines and Antibodies.  The NK cell clone  5F12 was  de- 
rived from human peripheral blood and cultured as described (20). 
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blastoid cell line  (21),  and the HLA-C transfectants of 721.221 
have been described (22).  Cell-surface expression of class I alleles 
was periodically  tested by FACS  |  analysis (Becton Dickinson & Co., 
Mountain View, CA) using the W6/32 mAb (mouse tgG2a anti- 
HLA-A, -B, and -C; American Type Culture Collection, P`ock- 
ville, MD) and the F4/326 mAb (mouse IgG1 anti-HLA-C; kindly 
provided by Soo Young Yang,  Sloan-Kettering Institute, New 
York,  NY;  23).  Anti-p58 KIP. monoclonal  antibody HP-3E4 
(mouse IgM) has been previously described (4). The anti-mouse 
IgM mAb b-7-6 (rat IgG1, kindly provided by Dr. John Cambier, 
National Jewish Center, Denver, CO) was conjugated to cyano- 
gen bromide-activated Sepharose 4B  beads  (Phannacia Biotech 
Inc., Piscataway, NJ) according to the manufacturer's instructions. 
Anti-PTP-1C antibody (rabbit polyclonal) and horseradish perox- 
idase (HR.P)-conjugated antiphosphotyrosine mAb (4G10; mouse 
IgG2b) were  purchased  from  Upstate  Biotechnology Inc.  (Lake 
Placid, NY). Monoclonal anti-PTP-1C  (mouse IgG1) was from 
Transduction  Laboratories  (Lexington,  KY)  and  was  detected 
with rabbit anti-mouse IgG-HP`P from Dako Corp. (Carpinteria, 
CA). The antiphosphotyrosine antibody PY20 (Transduction Lab- 
oratories) was conjugated to cyanogen bromide--activated  Sepharose 
4B beads (Pharmacia). 
Peptides.  The tyrosine-phosphorylated (p) and unphosphory- 
lated p58 peptide sequences were EVTYAQLNH (YAQL), EVT 
(p)YAQLNH  (pYAQL),  IVYTELPNAE  (YTEL),  and  IV(p) 
YTELPNAE  (pYTEL).  The  control phosphopeptide sequence 
was (p)YMAPYDNY (amino acids 739-746 from the PDGF re- 
ceptor [3; 24). Peptides were synthesized with a carboxy-terminal 
amide by Quality Controlled Biochemicals, Inc. (Hopkinton, MA) 
and  purified  by  reversed-phase  (ri0) HPLC.  Their  purity  was 
>97%, as assessed by rpHPLC, mass spectrometry, and 31p-NMP`. 
Peptides were coupled to AminoLink Plus coupling gel (1 mg/1 ml 
packed gel; Pierce Chemical Co., I<ockford, IL) overnight at 4~ 
and pH 7.2,  according to the manufacturer's instructions. Cou- 
pling efficiency from the supernatant was determined by moni- 
toring rpHPLC  column  elution at  OD220. Peptide beads  (~15 
~g/precipitation) were used immediately after coupling. 
Cell-su~ace ~2Sl-Labeli~g.  Cells were first labeled with a water- 
soluble Bolton-Hunter reagent  (36  Izg/ml Sulfo-SHPP; Pierce) 
according to the method of Portol& et al. (25) and subsequently 
with  Na125I (0.5  mCi/50  million cells;  Amersham,  Arlington 
Heights,  IL) using Iodogen (Pierce), according to the manufac- 
turer's instructions. 
Cytosolic Calcium Measurement of NK Cells Conjugated with  Tu- 
mor Target Cells.  The  NK  cell  clone  5F12  was  loaded  with 
Indo-1  AM  (Sigma Immunochemicals,  St.  Louis,  MO),  as de- 
scribed (26). Cells were mixed at a 2:1 ratio with 721.221  cells or 
with HLA-Cw4, -Cw5 transfectants of  721.221, centrifuged 1 rain 
at 400 g, incubated 2 min at 37~  resuspended, and analyzed on 
a  Coulter Elite Flow cytofluorimeter (Coulter Electronics Inc., 
Hialeah, FL)  to detect Ca  2+  fluxes and conjugate formation, as 
described (26).  In some experiments, target cells were preincu- 
bated for 30 rain at 4~  with the anti-HLA-C antibody F4/326 
or the anti-pan MHC class I antibody W6/32 or the anti-CD19 
antibody (clone HD37; Boehringer Mannheim, Indianapolis, IN) 
before mixing. Only live (based on forward scatter [FSC] criteria) 
and indo-l-loaded cells (based on 405-nM vs. 525-nM emission 
spectra)  were included in the analysis. In this way, the unloaded 
target cells were only visible when conjugated with a loaded NK 
cell. Because conjugates have a higher FSC than single cells, we 
could  directly  correlate  mean  cytosolic  Ca  2+  concentrations 
within the conjugated NK cell populations. 
Metabolic Labeling with [3sS]Cysteine/Methionine.  Cells  were 
washed twice with PBS and resuspended at 4 million/nil in cys- 
teine/methionine-free DME (Sigma) containing 10% FCS (TBS- 
dialyzed) and 1,000 U/ml rlL-2. [3SS]methionine/cysteine  (Amer- 
sham) was added at 0.1  bLCi/ml, and ceils were sealed in a 75-cm  2 
culture flask and incubated at 37~  for 4 h.  Cells were washed 
twice before subsequent lysis. 
Cell Stimulations.  For phenylarsine  oxide  (PAO)  treatment, 
30 million NK cells/ml were unstimulated (-) or stimulated (+) 
for 2 min with 100 ~M PAO (1 pA of 100 mM stock in DMSO) 
in a 37~  shaking heat block. An aliquot of 1 million cells was lysed 
in 4￿  reducing Laemmli sample buffer (27) and immediately fro- 
zen in liquid nitrogen, while the remainder was rapidly centri- 
fuged, lysed in 1% Triton )(-100 buffer, and subjected to immu- 
noprecipitation (see  below).  This  PAO  treatment  regimen  has 
been shown to produce optimal global tyrosine phosphorylation 
in T and B cells (28-30). In conjugation experiments, 50 million 
NK cell clones (5F12)  and/or 25 million target cells were mixed 
in 2  ml of IMDM medium at 37~  in a  14-ml round-bottom 
tube and immediately centrifuged at 2200  rpm for 5 s. Pelleted 
cells were incubated at 37~  for 2 rain, mixed with  10 ml ice- 
cold PBS containing 200 IzM sodium orthovanadate, pelleted for 
2 min at 1,600  rpm, lysed in  1% Triton X-100 buffer, and sub- 
jected to immunoprecipitation (see below). 
Protein Precipitations with Antibodies  and Peptides.  Cells were 
lysed on ice in 1% Triton X-100 (Surfact-Amps; Pierce), 10 mM 
Tris, pH 7.4,  150 mM NaC1, 2 n~M Na orthovanadate, 1 mM Pe- 
fabloc SC (Boehringer-Mannheim), 0.4 mM EDTA, 10 mM NaF, 
and 1 p~g/ml each ofleupeptin, aprotinin, and soybean trypsin in- 
hibitor (all from Sigma). Lysates were cleared by centrifugation at 
12,000 rpm and precipitated with antibodies or gel-coupled pep- 
tides at 4~  for 2-4 h.  HP-3E4  (I-3 pA of ascites/sample) was 
immunoprecipitated with b-7-6-coupled Sepharose, and W6/32 
(100 I*1 culture supernatant/sample) was precipitated with protein 
A-Sepharose (Pharmacia). All precipitates were washed five to six 
times with lysis buffer and resuspended in reducing Laemmli sam- 
ple buffer (27). 
Immunoblotting.  Precipitated samples were  boiled for 5  rain 
and  separated  on  discontinuous  SDS-PAGE  according  to  the 
method of Laemmli (27). Proteins were electrophoretically trans- 
ferred  to  nitrocellulose  (Hybond-C  Extra;  Amersham)  and 
blocked  with  5%  BSA.  Membranes  were  probed  with  either 
Hp`P-coupled 4G10  (375  ng/ml) or initially with anti-PTP-1C 
and  secondarily with  HI<P-coupled protein  G  or rabbit  anti- 
mouse  IgG-HP`P.  Immunoblotted proteins were  visualized by 
chemiluminescence  using  the  ECL  detection  reagents  (Amer- 
sham).  Membranes were stripped of antibody by incubating for 
30 lrfin at 50~  in 100 mM 2-ME, 2% SDS, 62.5 mM Tris, pH 
6.7 according to a protocol supplied by Amersham. Stripped blots 
were  reprobed after blocking.  3SS-labeled  samples were  subse- 
quently autoradiographed from dried membranes. 
PTP-1C Phosphatase Assay.  The  src  family tyrosine kinase- 
derived phosphorylation site peptide P,I<LIEDAEYAAP`G (Santa 
Cruz Biotechnology) was 32p-phosphorylated by incubating for 
3 h with fyn kinase inmmnoprecipitates in the presence of [32p]ATP, 
and was purified on P81  paper (Whatman,  Clifton, NJ),  eluted 
with 100 mM NH4HCO3,  and lyophilized as described by Mat- 
thews et al.  (16).  PTP-IC phosphatase was purified from lysates 
of the  human  NK  cell clone,  NK3.3,  with  pYAQL  tyrosine 
phosphopeptide-coupled heads, eluted with 50 mM p-nitrophe- 
nyl phosphate, and washed and concentrated in a Centricon-30 
(Amicon, Inc., Beverly, MA). Dephosphorylation of the 32p-pep- 
tide substrate by purified PTP-1C was assayed in the presence of 
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ear range ofpeptide dephosphorylafion), as described by Stmeh et al. 
(31). About 50 ng of 32p-peptide  labeled with ".,55,000  cpm was 
added to each 50-1xl sample of assay mixture. 
Results 
Inhibition  of Cytotoxicity  of NK  Cell  Clones  by  Class  I 
Ligands  is  Paralleled by  Inhibition  of Calcium  Mobilization. 
The  human  NK  cell  clone  5F12  expresses  the  p58  KIR 
recognized  by  the  HP-3E4  mAb,  which  has  previously 
been shown to mediate  NK cell inhibition  by a group of 
HLA-C molecules on target cells that share Asn77-Lys  s~ (2). 
Indeed, in cytotoxicity assays, lysis of class I--deficient B cell 
line  721.221  by  5F12  was  inhibited  by  transfection  of 
HLA-Cw4, -Cw5, and -Cw6, whereas other HLA-C alle- 
les did not affect cytotoxicity (data not shown). 
To assess whether the inhibition of NK cell cytotoxicity 
was paralleled  by changes  in  calcium mobilization  in this 
clone, 5F12 was loaded with a calcium-reactive dye, indo-1, 
and conjugated with sensitive  or resistant  target cells.  Cy- 
tosohc calcium levels were measured in the  NK cells  that 
formed  conjugates.  Interaction  with  sensitive  target  cells 
substantially  elevated  the  mean  cytosohc calcium levels in 
the  conjugated  NK  cell population  (Fig.  1).  Conjugation 
with HLA-C-transfected resistant target cells, however, re- 
sulted in only a minimal increase of cytosohc calcium in the 
NK cells during the same time course. Interestingly, mask- 
ing of HLA-C in these resistant target cells with antibodies 
resulted in increased calcium mobilization in the NK cells 
(Fig.  1), while the isotype-matched, anti-CD19 antibody had 
no effect in control experiments  (data not shown).  There- 
fore,  the  NK  cell  calcium  mobilization  response  is  nega- 
tively  regulated  by  the  interaction  of inhibitory  receptor 
with HLA-C molecules expressed on resistant target cells. 
PTP-1C Associates with  Tyrosine-phosphorylated p58  KIR. 
Since in B  cells, CD22 and Fc~/P,.IIB1  inhibitory receptors 
downregulate  calcium mobilization by phosphorylation of 
ITIMs and binding with PTP-1C, we tested whether p58 
KIR  could  be  tyrosine  phosphorylated  in  NK  cells,  and 
whether the phosphorylated KIR could bind PTP-1C.  In 
initial  experiments,  we  induced  tyrosine  phosphorylation 
in human NK cells by a pharmacologic agent, PAO, a po- 
tent  phosphotyrosine  phosphatase  inhibitor  that  has  been 
shown to induce substantial  protein  tyrosine phosphoryla- 
tion in treated  T  and B  lymphocytes (28-30).  Aliquots of 
the  NK cell  clone  5F12  were  either  untreated  or treated 
with 100 IxM PAO for 2 min, then lysed and immunoprecip- 
itated with anti-p58 or anti-HLA class I antibodies.  Whole- 
cell lysates and immunoprecipitates were separated by SDS- 
PAGE  and  analyzed  by sequential  immunoblotting  using 
antiphosphotyrosine and and-PTP-1C antibodies￿9 
Antiphosphotyrosine  immunoblotting  revealed  substan- 
tial increases in tyrosine phosphorylation of many proteins 
in whole-cell lysates ofPAO-treated NK cells,  as compared 
to the untreated cells  (Fig. 2 A, left panels). PAO treatment 
also dramatically increased the intensity and number of ty- 
rosine  phosphorylated  species  in  p58  immunoprecipita- 
tions. The major tyrosine phosphoprotein in this immuno- 
precipitation directly overlapped with the p58 protein (Fig. 
2  B),  indicating  that  the  p58  KII:( is  inducibly  tyrosine 
phosphorylated by PAO treatment.  Additional p58-associ- 
ated tyrosine phosphoprotein bands were detected with ap- 
parent molecular masses of 63, 71, 74, 78, and 105 kD.  In 
control  MHC  class  I  immunoprecipitations,  a  single  ty- 
rosine phosphoprotein  of "~  kD  that was unaffected by 
PAO stimulation was detected. 
Anti-PTP-1C  immunoblotting detected  equal  amounts 
of a protein with the expected molecular mass of 65 kD in 
lysates from both untreated and PAO-treated cells  (Fig. 2 A, 
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Figure I.  NK cell calcium mobi- 
lization is inhibited by MHC class I 
recognition  on  cytotoxicity-resis- 
rant target cells. The NK cell clone 
5F12 was loaded with  indo-1 and 
centrifuged with  the  indicated tar- 
get cells before flow cytometric anal- 
ysis. Some target cells were preincu- 
bated for 30  min at 4~  with  the 
anti-HLA-C  antibody F4/326  or 
the anti-pan MHC class I antibody 
W6/32 before mixing. NK cells that 
are directly conjugated with targets 
exhibit distinct shift in  FSC  (indi- 
cated  by  brackets). The  405/525 
emission ratio direcdy correlates with 
the intracellular Ca  2+ concentration 
of the individual indo-l-loaded  NK 
cells. The mean fluorescence of the 
conjugated cell population is  indi- 
cated in the upper left comer of each 
panel￿9 Each panel represents individ- 
ual cell recordings accumulated dur- 
ing a 4-rain period. This profile was 
maintained for at least 15 rain (data 
not shown). 
95  Campbell  et al. Figure 2.  Phenylarsine oxide treatment of NK cells induces tyrosine phosphorylation of p58 receptor and association  of PTP-IC.  (A) The NK cell 
clone 5F12 was unstimulated (-) or stimulated (+) for 2 min with 100 txM PAO in a 37~  shaking block.  An aliquot of 1 million cells was immediately 
lysed in Laemmli buffer, while the remainder was lysed in 1% Triton X-100 buffer and immunoprecipitated with W6/32 (MHC)  or anti-p58 (p58) anti- 
bodies. A control was performed in which anti-p58 was identically precipitated from lysis buffer lacking cells (no cells), to rule out immunoblotting reac- 
tivity with the heavy chains of the immunoprecipitating antibody. Lysates and immunoprecipitates were separated by SDS-PAGE, transferred to nitrocel- 
lulose, immunoblotted with antiphosphotyrosine antibody (4G10-HRP; left panel), stripped,  and secondarily  immunoblotted with anti-PTP-1 C antibody 
(polyclonal;  nght panel).  (B) The NK cell clone 5F12 was surface 125I-labeled, lysed in 1% Triton X-100, and immunoprecipitated with either anti-MHC 
class I antibody W6/32 and protein A-Sepharose (MHC), or with the anti-p58 antibody and anti-mouse IgM (p58; HP-3E4 and b-7-6), or with the 
anti-mouse IgM alone (anti-IgM; b-7-6). Immunoprecipitates were separated  on SDS-PAGE, the gel was dried,  and labeled proteins were detected by 
autoradiography. 
right  panels).  Interestingly,  in  the  p58  lmmunoprecipitate 
from  PAO-treated  cells,  a  substantial  amount  of PTP-1C 
was  detected  in association with  the p58  KIR,  while  only 
minimal anti-PTP-1C  reactivity was observed in immuno- 
precipitates from untreated cells.  PTP-1C  was not detected 
in  anti-MHC  class  I  irmnunoprecipitates  from  either  un- 
treated  or  PAO-treated  cells.  In  conclusion,  these  results 
indicate  that PAO  induces  substantial tyrosine  phosphory- 
Figure  3.  PTP-1C  associates 
with tyrosine-phosphorylated  p58 
receptor in NK  cells conjugated 
with  resistant  target  cells. The 
NK  cell  line  5F12  was  conju- 
gated with target cells (721.221, 
sensitive  target and HLA-Cw4- 
transfected  721.221,  resistant tar- 
get) by centrifugation as detailed 
in  Materials  and  Methods.  Ly- 
sates of conjugated cells or iden- 
tically treated NK ceils or target 
cells were precleared  (b-7-6),  im- 
munoprecipitated with  anti-p58 
antibody  (HP-3E4  and  b-7-6), 
and secondarily  immunoprecipi- 
tated  with  antiphosphotyrosine 
antibody  (PY20).  Immunopre- 
cipitates and NK cell lysate (I mil- 
lion cells lysed in sample  buffer) 
were  separated  on  SDS-PAGE 
and probed first with antiphospho- 
tyrosine  antibody  (4G10-HRP) 
and secondarily  with  anti-PTP- 
I C  (monoclonal and goat  anti- 
mouse  IgG-HRP).  The  migra- 
tion  of  p58  and  PTP-1C  are 
marked with arrows. 
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Moreover, PAO induces the phosphorylation of and/or as- 
sociation  of  several  additional  tyrosine  phosphoproteins 
that coprecipitate with the p58 KIR. 
PTP-IC Is Recruited to p58 KIR upon NK Cell Conjuga- 
tion with Target Cells.  Since PAO treatment is a nonphysi- 
ological  stimulus  of  tyrosine  phosphorylation,  we  also 
tested whether PTP-1C  could inducibly associate with p58 
KIR upon receptor ligation that occurs during the conjuga- 
tion of our characterized NK cell clone 5F12 with target cells. 
As shown  in Fig. 3,  significant tyrosine phosphorylation is 
induced upon conjugation of the NK cells with either sen- 
sitive or resistant target cells, as has been shown previously 
by Kaufman  et al.  (18).  Immunoprecipitation of p58  KIR 
from lysates of both cell conjugates revealed that a protein 
migrating at  58  kD  was  tyrosine phosphorylated and  that 
numerous  additional tyrosine phosphorylated proteins be- 
came  associated with  the  receptor.  Immunoblotting with 
anti-PTP-1C demonstrated that the phosphatase indeed be- 
comes associated with p58  KIR  upon  conjugation of NK 
cells with resistant targets. To  a lesser extent, PTP-1C  also 
associated with p58  KIR  upon  conjugation with sensitive 
target  cells, which  was  also  observed in  several additional 
experiments.  Nevertheless,  PTP-1C  associated more  eflq- 
ciendy with p58 KIR upon NK cell interaction with resis- 
tant target cells. 
Both Tyrosine Residues in the Cytoplasmic Domain of  p58 KIR 
Bind and Activate PTP-tC upon Phosphorytation.  Since the 
cytoplasmic domain of p58 KIR has two YXXL motifs, the 
role of phosphorylation of each of these motifs on PTP-1 C 
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Figure 4.  Tyrosine phosphopeptides bind several 
proteins from NK cell lysates, including PTP-1C, 
and enhance PTP-1C phosphatase activity, (A) The 
NK cell clone 5F12 was 3SS-metabolically  labeled 
and lysed in 1% Triton X-100  buffer (25  million 
cells/sample lysed in  0.5  ml).  The  lysates were 
cleared  by  centrifugation  and  precipitated  with 
peptides coupled  to  AminoLink gel.  Precipitates 
were  separated by SDS-PAGE and transferred to 
nitrocellulose. The membrane was immunoblotted 
with anti-PTP-1C (polyclonal;  right  panel) and sub- 
sequently dried  and  autoradiographed (left panel). 
(B) Enzymatic activity of PTP-1C was assayed by 
measuring  the  radioactivity  released  from  a 
[32p]phosphotyrosine peptide substrate in the pres- 
ence or absence of the  p58-derived peptides and 
phosphotyrosine peptides, as detailed in Materials 
and Methods. The cpm of  32p-o4 released are aver- 
ages with range bracketed from duplicate samples, 
as measured by scintillation  counting and are from a 
representative of three experiments. The PDGF re- 
ceptor  tyrosine  phosphopeptide  (pPDGFR)  en- 
compassed  residues 739-746.  The  combination 
samples (pYTEL +  pYAQL) were treated with the 
indicated concentration of each phosphopeptide. binding  was  examined with  synthetic  tyrosine phospho- 
peptides.  Peptides  containing  sequences  surrounding  the 
p58  KItL  tyrosine  residues  were  coupled  to  AminoLink 
Plus coupling gel and used as affinity matrices to bind pro- 
teins from Triton X-100 lysates of  35S-metabolical]y  labeled 
NK cell clone 5F12.  Few,  if any, proteins bound to un- 
phosphorylated  tyrosine-containing  peptides,  but  phos- 
phorylated  versions  of the  same  peptides  bound  several 
distinct protein species  (Fig. 4 A,  left panel).  The pYAQL- 
containing phosphopeptide bound at least nine proteins of 
54, 65, 69,  81, 83,  102,  i08,  120, and 131  kD while the 
pYTEL-containing phosphopeptide bound a subset of the 
same proteins of 65, 69, 81,  108,  120, and 131  kD. Alter- 
natively, a control tyrosine phosphopeptide from the cyto- 
plasmic domain of the PDGF receptor-J3 exhibited differ- 
ent binding specificity and adsorbed three major proteins 
(60,  81,  and  90  kD).  The  65-kD  protein band  that was 
bound by both of the p58 phosphopeptides corresponded 
to the predicted molecular mass for PTP-1C.  Subsequent 
immunoblotting identified this band as PTP-1C (Fig. 4 A, 
right panel).  Nevertheless, PTP-1C routinely bound more 
to the pYAQL peptide than to the pYTEL peptide and was 
less susceptible to  elution by 50  mM p-nitrophenylphos- 
phate when associated with the pYAQL peptide (data  not 
shown).  Thus,  both  tyrosine residues  in  the  cytoplasmic 
domain of p58 have the capacity to bind PTP-1C and ad- 
ditional proteins exhibit distinct binding capacities towards 
the phosphopeptides. 
Both of the p58-derived tyrosine phosphopeptides ele- 
vated enzymatic activity of PTP-1C  in  a  concentration- 
dependent manner, as presented in Fig.  4 B. The pYAQL 
phosphopeptide was more potent in enhancing phosphatase 
activity than pYTEL, which parallels  the PTP-1C-binding 
capacity of the phosphopeptides. The combination of both 
phosphopeptides  was  at  best  additive.  Unphosphorylated 
peptides or the PDGF receptor-derived tyrosine phospho- 
peptide did not stimulate phosphatase activity. 
Discussion 
These observations provide advances in our understand- 
ing of the  mechanism  of inhibitory receptor function in 
human NK cells. It has been previously shown that inhibi- 
tion of the inositol phosphate turnover and calcium mobili- 
zation response are critical components of the downregula- 
tion of NK cell cytotoxicity by class I molecules (18).  Our 
results parallel these observations and imply a role for PTP- 
1C as a cytosolic mediator of KilL function. Upon tyrosine 
phosphorylation, the p58 KIlL binds to PTP-1C via two 
separate ITIM motifs, which may interact with one or both 
of the SH2 domains of PTP-1C. Recruitment of PTP-1C 
is paralleled by activation, as suggested by the stimulation of 
tyrosine phosphatase activity of PTP-1C in vitro (Fig. 4 B) 
by p58-derived phosphotyrosine peptides. 
Tyrosine phosphorylation of p58 KIR and association of 
PTP-1C occurs in response to pharmacological stimulation 
with PAO, as well as to physiological conjugation of NK 
ceils  with  resistant  target  cells.  In  our  experiments,  p58 
KIP, is also tyrosine phosphorylated when NK cells are con- 
jugated with sensitive target cells.  This is probably caused 
by a profound global tyrosine phosphorylation that is stim- 
ulated in NK cells  that interact with sensitive target cells 
(18).  Still,  PTP-1C is more efficiently recruited when the 
receptor is specifically engaged by the inhibitory ligand. It 
is also likely that PTP-1C is only one of the components of 
the inhibitory cascade.  Further characterization of the addi- 
tional proteins that bind p58 KIR (Fig. 3) and KIR phos- 
phopeptides (Fig. 4 A) is underway. 
The apparent role for PTP-1C in the inhibitory receptor 
mechanism is strikingly similar to the mechanism by which 
the  Fc',/RIIB1  and  CD22  receptors  negatively  regulate 
BCR function (9,  17). A  critical aspect of the mechanism 
of these inhibitory receptors is their direct association with 
the BCR, thereby bringing the phosphatase directly to the 
antigen receptor and negatively regulating calcium mobili- 
zation through the antigen receptor. FcylLIIB1 can be re- 
cruited to the BCR by bound antigens with associated se- 
rum IgG (9, 11, 12), whereas CD22 is believed to be weakly 
associated with the BClL (17, 32). It is not known whether 
KIRs are associated with an activating receptor(s) and whether 
this  association  is  required  to  induce  negative  signaling. 
Previous experiments with bystander ceils have shown that 
NK cell cytotoxicity against  class I-deficient target cells is 
not affected by the presence of class I-positive bystanding 
cells  (22).  This lack  of bystander effect suggests  that  the 
KilLs generate a negative signaling directed at the interface 
of effector-target cell interaction rather than a global  cell 
anergy. Thus, colocalization of KIRs with stimulatory re- 
ceptors may be required to mediate  cross-talk inhibition. 
Further studies are required to characterize the human NK 
cell stimulatory receptors, determine whether they associ- 
ate  with  inhibitory receptors, and  establish  how they are 
regulated through PTP-1C recruitment. 
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Note added in proof." Since original submission of this manuscript, similar results were reported by Burshtyn 
and colleagues (Burshtyn,  D.N., A.M. Scharenberg, N. Wagtmann, S. R.ajagopalan, K. Berrada, T. Yi, J.-P. 
Kinet, and E.O. Long. 1996. R.ecmitment of tyrosine phosphatase HCP by the killer cell inhibitory recep- 
tor. Immunity. 4:77-85). The PTP-1C phosphatase  was also renamed SHP-1  (Adachi, M., E.H. Fischer, J. 
Ihle, K. Imai, F. Jirik, B. Neel, T. Pawson, S.-H. Shen, M. Thomas, A. Ullrich, and Z. Zhao. 1996. Mam- 
malian SH2-containing protein tyrosine phosphatases.  Cell. 85:15). 
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